|
Volumn 32, Issue 2, 2007, Pages 139-150
|
Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center;Indicacaões e efeitos adversos das drogas anti-TNFalpha em reumatologia pediátrica: experiencia de um unico centro.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
ARTICLE;
CHILD;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
MALE;
PRESCHOOL CHILD;
RETROSPECTIVE STUDY;
RHEUMATIC DISEASE;
ADOLESCENT;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
RECEPTORS, TUMOR NECROSIS FACTOR;
RETROSPECTIVE STUDIES;
RHEUMATIC DISEASES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 34848926871
PISSN: 0303464X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|